Company intelligence / Profile preview
Felicitex Therapeutics
Natick, Massachusetts, United Statesfelicitex.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Preclinical
01
Overview
Felicitex Therapeutics is developing small molecule therapies that selectively disrupt dormant and active cancer cells. Their approach aims to overcome resistance mechanisms by preventing tumor cell dormancy—a key factor in relapse and metastasis. As of early 2023, all programs are preclinical with IND filings planned for their lead compounds FX‑1610 (pediatric leukemia), FX‑7742 (solid tumors), and FX‑9847 (backup compound). No clinical results are available yet.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculesChemical drugs
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Selvita S.A.: Strategic R&D collaboration focused on targeting quiescent/non-responsive cancer cells using kinase inhibitor platforms. Selvita provides research funding and shares in future revenues/milestones/royalties from jointly discovered drugs.
Beyond the preview
Go deeper on Felicitex Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Felicitex Therapeutics.